美诺华上涨6.78%，报30.41元/股

Core Viewpoint - Meihua's stock price increased by 6.78% on August 19, reaching 30.41 yuan per share, with a total market capitalization of 6.685 billion yuan [1] Group 1: Company Overview - Ningbo Meihua Pharmaceutical Co., Ltd. is located in Ningbo High-tech Zone and specializes in the research, production, and sales of specialty raw materials and finished pharmaceuticals [1] - The company is one of the largest exporters of specialty raw materials to Europe in China, with products covering cardiovascular, central nervous system, and gastrointestinal treatment areas [1] - Since its listing, the company has adhered to a development strategy of "internal growth + external expansion," focusing on continuous R&D innovation and business development [1] Group 2: Financial Performance - As of March 31, Meihua had 27,600 shareholders, with an average of 7,720 circulating shares per person [2] - For the first quarter of 2025, Meihua achieved operating revenue of 276 million yuan, a year-on-year increase of 5.22% [2] - The net profit attributable to shareholders for the same period was 21.22 million yuan, reflecting a year-on-year growth of 51.12% [2]